SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-12-079608
Filing Date
2012-11-21
Accepted
2012-11-21 16:03:14
Documents
2
Period of Report
2012-11-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a12-27646_18k.htm 8-K 25587
2 EX-10.1 a12-27646_1ex10d1.htm EX-10.1 57502
  Complete submission text file 0001104659-12-079608.txt   84313
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32966 | Film No.: 121221271
SIC: 2836 Biological Products, (No Diagnostic Substances)